Primary Pulmonary Coccidioidomycosis in Persons with Community Acquired Pneumonia in Endemic Areas
Background Coccidioidomycosis is a frequent cause of community acquired pneumonia (CAP) in endemic areas of the United States. Methods This observational study included persons ≥ 14 years of age with CAP at Arizona or California study sites. The primary outcome was prevalence of PPC among patients with CAP. Secondary outcomes included predictors of PPC among those with CAP and clinical improvement in PPC. Associations between the SAnds-PPC clinical score over time and receipt of antifungal therapy among those with PPC were analyzed in a linear mixed model. Results Among 496 participants with CAP, the prevalence of PPC was 23.4% (95% CI: 19.9, 27.3). The odds of having PPC decreased for each year increase in age (odds ratio [OR]: 0.98; 95% CI: 0.97, 1.00); was lower for females than males (OR: 0.55; 95% CI: 0.33, 0.93); and higher for Hispanic ethnicity versus non-Hispanic ethnicity (OR: 1.98; 95% CI: 1.08, 3.64) Among 215 participants with PPC, a 50% reduction in the SAnds-PPC score (clinical response) was achieved by 67% of participants by Day 85, respectively. A linear mixed model controlling for visit, age, site, ethnicity, race and asthma history did not detect a difference in the average SAnds-PPC scores over time between participants who did and did not receive antifungal therapy (Parameter Estimate 0.79; 95% CI: -0.09, 1.67). Conclusions This study ascertained a high prevalence of coccidioidomycosis among patients with CAP in endemic areas. This study was not designed to definitively determine the impact of antifungal therapy for PPC.
Authors
- Mohamed A. Fayed (ORCID: https://orcid.org/0000-0001-6474-1682)
- Emmanuel B. Walter (ORCID: https://orcid.org/0000-0001-6502-6736)
- Aneesh T. Narang
- Yashika C. Johnson
- Neil M. Ampel (ORCID: https://orcid.org/0000-0003-2872-4396)
- Alice K. Henning (ORCID: https://orcid.org/0000-0002-6338-6890)
- Aung K. Htoo
- Susanna Naggie (ORCID: https://orcid.org/0000-0001-7721-6975)
- Alison Wall (ORCID: https://orcid.org/0000-0002-6720-0977)
- Royce H. Johnson (ORCID: https://orcid.org/0009-0007-5515-2633)
- George R. Thompson (ORCID: https://orcid.org/0000-0001-8518-5750)
- Arash Heidari (ORCID: https://orcid.org/0000-0003-1091-348X)
- Jonathan Hien Truong
- Fariba Donovan (ORCID: https://orcid.org/0000-0002-6203-5693)
- John N. Galgiani (ORCID: https://orcid.org/0000-0002-7882-1883)
- Grace N Davis
- David Bronstein
- Rana Shenoy
- Soe Win
- for the Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis (SAnds-PPC) Study Group
- Armen Arshakyan
Institutions
- Kaiser Permanente (US)
- University of Arizona (US)
- University of California, Los Angeles (US)
- Duke University (US)
- University of California, San Francisco (US)
- Kern Medical Center (US)
- Dignity Health (US)
- Emmes (United States) (US)
- University of California Davis Medical Center (US)
- BIO5 Institute (US)
- University of Arizona College of Medicine- Phoenix (US)
- Duke Clinical Research Institute (US)
- Morehouse School of Medicine (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1093/ofid/ofag749
- Primary Topic
- Fungal Infections and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00